Finanzwire Finanzwire
Basculer en Français
11166 Companies
246602 Keywords
174550 Articles
133184 Press releases
Headlines Articles Press releases Beta Bionics Remove
  1. Home
  2. Companies
  3. Beta Bionics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/06/2024 at 13:06, 2 years 5 months ago

    Xeris Biopharma Announces Collaboration With Beta Bionics for Bi-Hormonal Pump Development

    Beta Bionics Diabetes Treatment Xeris Biopharma Bi-hormonal Pump XeriSol Technology
  • PRESS RELEASE

    published on 05/06/2024 at 13:01, 2 years 5 months ago

    Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

    Xeris Biopharma partners with Beta Bionics for the development of a new glucagon product with XeriSol™ technology for bi-hormonal pump systems
    Beta Bionics Xeris Biopharma Bi-hormonal Pump Glucagon XeriSol™ Technology
    Logo of Beta Bionics
  • PRESS RELEASE

    published on 12/07/2023 at 14:00, 2 years 10 months ago

    Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas With Dexcom G7 CGM System

    Beta Bionics, Inc. will launch the iLet Bionic Pancreas with Dexcom G7 CGM System on Dec. 18, 2023, allowing users to update without additional hardware costs. The system streamlines diabetes management with quick and easy integration and offers choice to users. Dexcom G7 is the fastest and most accurate CGM available
    Beta Bionics ILet Bionic Pancreas Dexcom G7 CGM System Diabetes Management
    Logo of Beta Bionics
  • PRESS RELEASE

    published on 08/30/2023 at 21:20, 3 years 1 month ago

    Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

    Logo of Beta Bionics
Accesswire
  • Published on 10/13/2026 at 15:00, 14 minutes ago

    Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend

  • Published on 10/13/2026 at 14:45, 29 minutes ago

    Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

  • Published on 10/13/2026 at 14:31, 43 minutes ago

    First Breach Completes First Autonomous Flight of Proprietary Drone Prototype

  • Published on 10/13/2026 at 14:10, 1 hour 4 minutes ago

    NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements

  • Published on 10/13/2026 at 14:00, 1 hour 14 minutes ago

    Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

View all ACCESSWIRE
EQS Group
  • Published on 10/13/2026 at 15:06, 7 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 10/13/2026 at 15:05, 9 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

  • Published on 10/13/2026 at 15:05, 9 minutes ago

    Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats

  • Published on 10/13/2026 at 15:03, 10 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

  • Published on 10/13/2026 at 15:02, 12 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

View all EQS
Les Echos
  • Published on 10/13/2026 at 09:04, 6 hours 9 minutes ago

    Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards

  • Published on 10/12/2026 at 17:59, 21 hours 14 minutes ago

    Reporting on share buyback transactions carried out between October 7 and October 9, 2026

  • Published on 10/12/2026 at 17:45, 21 hours 29 minutes ago

    Weekly share buyback

  • Published on 10/12/2026 at 17:45, 21 hours 29 minutes ago

    Declaration of transactions on own shares from October 5, 2026 to October 11, 2026

  • Published on 10/12/2026 at 15:47, 23 hours 26 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy